Drugs Approved by the FDA

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Mallinckrodt Group
Approval Status: Approved August 1996
Treatment for: chronic pain

General Information

Anexsia has been approved for the treatment of chronic pain. Anexsia is a new dosage strength of medication combining the pain relievers acetaminophen and hydrocodone, an opiate-based narcotic. This new dosage will be the strongest combination of these two analgesics on the market. Anexsia is taken orally and is used to treat moderate to moderately severe pain.